{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:36:53Z","timestamp":1793090213874,"version":"4.5.0"},"reference-count":31,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2013,1,29]],"date-time":"2013-01-29T00:00:00Z","timestamp":1359417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2013,2]]},"abstract":"<jats:sec>\n                    <jats:title>What's known on the subject? and What does the study add?<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            Disorders of ejaculation and orgasm are common, even in men with only mild erectile dysfunction (\n                            <jats:styled-content style=\"fixed-case\">ED<\/jats:styled-content>\n                            ).\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            Treatment with the phosphodiesterase type\u20105 inhibitor tadalafil was associated with improvements in ejaculatory and orgasmic function. Patients with residual ejaculatory or orgasmic dysfunction experience reduced sexual satisfaction. These findings need to be corroborated in further clinical trials involving men without\n                            <jats:styled-content style=\"fixed-case\">ED<\/jats:styled-content>\n                            .\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            To compare effects of tadalafil on ejaculatory and orgasmic function in patients presenting with erectile dysfunction (\n                            <jats:styled-content style=\"fixed-case\">ED<\/jats:styled-content>\n                            ).\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            To determine the effects of post\u2010treatment ejaculatory dysfunction (\n                            <jats:styled-content style=\"fixed-case\">EjD<\/jats:styled-content>\n                            ) and orgasmic dysfunction (\n                            <jats:styled-content style=\"fixed-case\">OD<\/jats:styled-content>\n                            ) on measures of sexual satisfaction.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>\n                            Data from 17 placebo\u2010controlled 12\u2010week trials of tadalafil (5, 10, 20\u2009mg) as needed in patients with\n                            <jats:styled-content style=\"fixed-case\">ED<\/jats:styled-content>\n                            were integrated.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            <jats:styled-content style=\"fixed-case\">EjD<\/jats:styled-content>\n                            and\n                            <jats:styled-content style=\"fixed-case\">OD<\/jats:styled-content>\n                            severities were defined by patient responses to the\n                            <jats:styled-content style=\"fixed-case\">I<\/jats:styled-content>\n                            nternational\n                            <jats:styled-content style=\"fixed-case\">I<\/jats:styled-content>\n                            ndex of\n                            <jats:styled-content style=\"fixed-case\">E<\/jats:styled-content>\n                            rectile\n                            <jats:styled-content style=\"fixed-case\">F<\/jats:styled-content>\n                            unction, question 9 (\n                            <jats:styled-content style=\"fixed-case\">IIEF<\/jats:styled-content>\n                            \u2010\n                            <jats:styled-content style=\"fixed-case\">Q<\/jats:styled-content>\n                            9; ejaculation) and\n                            <jats:styled-content style=\"fixed-case\">IIEF<\/jats:styled-content>\n                            \u2010\n                            <jats:styled-content style=\"fixed-case\">Q<\/jats:styled-content>\n                            10 (orgasm), respectively.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            Satisfaction was evaluated using the intercourse and overall satisfaction domains of the\n                            <jats:styled-content style=\"fixed-case\">IIEF<\/jats:styled-content>\n                            and Sexual Encounter Profile question 5.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            Analyses of covariance were performed to compare mean ejaculatory function and orgasmic function, and chi\u2010squared tests evaluated differences in endpoint responses to\n                            <jats:styled-content style=\"fixed-case\">IIEF<\/jats:styled-content>\n                            \u2010\n                            <jats:styled-content style=\"fixed-case\">Q<\/jats:styled-content>\n                            9 and\n                            <jats:styled-content style=\"fixed-case\">IIEF<\/jats:styled-content>\n                            \u2010\n                            <jats:styled-content style=\"fixed-case\">Q<\/jats:styled-content>\n                            10.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>A total of 3581 randomized subjects were studied.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            Treatment with tadalafil 10 or 20\u2009mg was associated with significant increases in ejaculatory and orgasmic function (vs placebo) across all baseline\n                            <jats:styled-content style=\"fixed-case\">ED<\/jats:styled-content>\n                            ,\n                            <jats:styled-content style=\"fixed-case\">EjD<\/jats:styled-content>\n                            , and\n                            <jats:styled-content style=\"fixed-case\">OD<\/jats:styled-content>\n                            severity strata.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            In the tadalafil group, 66% of subjects with severe\n                            <jats:styled-content style=\"fixed-case\">EjD<\/jats:styled-content>\n                            reported improved ejaculatory function compared with 36% in the placebo group (\n                            <jats:italic>P<\/jats:italic>\n                            &lt; 0.001).\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            Similarly, 66% of the tadalafil\u2010treated subjects (vs 35% for placebo;\n                            <jats:italic>P<\/jats:italic>\n                            &lt; 0.001) with severe\n                            <jats:styled-content style=\"fixed-case\">OD<\/jats:styled-content>\n                            reported improvement.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            Residual severe\n                            <jats:styled-content style=\"fixed-case\">EjD<\/jats:styled-content>\n                            and\n                            <jats:styled-content style=\"fixed-case\">OD<\/jats:styled-content>\n                            after treatment had negative impacts on sexual satisfaction.\n                          <\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            Limitations of the analysis include its retrospective nature and the use of an instrument (\n                            <jats:styled-content style=\"fixed-case\">IIEF<\/jats:styled-content>\n                            ) with as yet unknown performance in measuring treatment responses for\n                            <jats:styled-content style=\"fixed-case\">EjD<\/jats:styled-content>\n                            and\n                            <jats:styled-content style=\"fixed-case\">OD<\/jats:styled-content>\n                            .\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>Tadalafil treatment was associated with significant improvements in ejaculatory function, orgasmic function and sexual satisfaction.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Proportions of subjects reporting improved ejaculatory or orgasmic function were \u2248 twofold higher with tadalafil than with placebo.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>\n                            These findings warrant corroboration in prospective trials of patients with\n                            <jats:styled-content style=\"fixed-case\">EjD<\/jats:styled-content>\n                            or\n                            <jats:styled-content style=\"fixed-case\">OD<\/jats:styled-content>\n                            (without\n                            <jats:styled-content style=\"fixed-case\">ED<\/jats:styled-content>\n                            ).\n                          <\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/j.1464-410x.2012.11656.x","type":"journal-article","created":{"date-parts":[[2013,1,29]],"date-time":"2013-01-29T10:36:49Z","timestamp":1359455809000},"page":"334-343","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Effects of 12 weeks of tadalafil treatment on ejaculatory and orgasmic dysfunction and sexual satisfaction in patients with mild to severe erectile dysfunction: integrated analysis of 17 placebo\u2010controlled studies"],"prefix":"10.1111","volume":"111","author":[{"given":"Darius A.","family":"Paduch","sequence":"first","affiliation":[{"name":"Department of Urology and Reproductive Medicine Weill Cornell Medical College  New York NY"},{"name":"Consulting Research Services, Inc.  Red Bank NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Bolyakov","sequence":"additional","affiliation":[{"name":"Department of Urology and Reproductive Medicine Weill Cornell Medical College  New York NY"},{"name":"Consulting Research Services, Inc.  Red Bank NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula K.","family":"Polzer","sequence":"additional","affiliation":[{"name":"Lilly Research Laboratories Eli Lilly  Indianapolis IN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven D.","family":"Watts","sequence":"additional","affiliation":[{"name":"Lilly Research Laboratories Eli Lilly  Indianapolis IN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,1,29]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2008.06.048"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2003.08.015"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijir.3901250"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-004-0486-9"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.6.537"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2605.2005.00593.x"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7412.423"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2008.00825.x"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/00926230601098449"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/00926230701385548"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1258\/095646206775220450"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7412.426"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.133.5.559"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3999(79)90018-7"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2011.10504.x"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-7358(00)00069-6"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01542074"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2007.08.005"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1Q008"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0272.2008.00910.x"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1159\/000112607"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1159\/000102909"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2042.2007.01606.x"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000158456.41788.93"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2007.07038.x"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2004.04819.x"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(97)00238-0"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-004-0488-7"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2005.20351.x"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/ijir.2009.21"},{"key":"e_1_2_9_32_1","first-page":"26","article-title":"The phosphodiesterase type\u20105 inhibitor, tadalafil, improves depressive symptoms, ameliorates memory impairment, as well as suppresses apoptosis and enhances cell proliferation in the hippocampus of maternal\u2010separated rat pups","volume":"488","author":"Baek S\u2010B","year":"2011","journal-title":"Eur Urol"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1464-410X.2012.11656.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1464-410X.2012.11656.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T11:28:01Z","timestamp":1761737281000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/j.1464-410X.2012.11656.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,29]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["10.1111\/j.1464-410X.2012.11656.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1464-410x.2012.11656.x","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"value":"1464-4096","type":"print"},{"value":"1464-410X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,29]]},"assertion":[{"value":"2013-01-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}